Renovaro Biosciences Inc. (RENB)
RENB Stock Price Chart
Explore Renovaro Biosciences Inc. interactive price chart. Choose custom timeframes to analyze RENB price movements and trends.
RENB Company Profile
Discover essential business fundamentals and corporate details for Renovaro Biosciences Inc. (RENB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
7 Feb 2018
Employees
25.00
Website
https://www.renovarobio.comCEO
David H. Weinstein
Description
Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.
RENB Financial Timeline
Browse a chronological timeline of Renovaro Biosciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 15 May 2025
EPS came in at $0.00 .
Earnings released on 19 Feb 2025
EPS came in at -$0.02 .
Earnings released on 10 Oct 2024
EPS came in at -$0.45 .
Earnings released on 30 Sept 2024
EPS came in at -$0.16 , while revenue for the quarter reached $181.45K .
Earnings released on 15 May 2024
EPS came in at -$0.08 .
Earnings released on 14 Feb 2024
EPS came in at -$0.07 .
Earnings released on 2 Oct 2023
EPS came in at -$0.41 .
Earnings released on 29 Sept 2023
EPS came in at -$0.36 .
Earnings released on 12 May 2023
EPS came in at -$0.08 .
Earnings released on 31 Mar 2023
EPS came in at -$0.08 .
Earnings released on 30 Sept 2022
EPS came in at -$0.14 .
Earnings released on 29 Jun 2022
EPS came in at -$1.70 .
Earnings released on 30 Mar 2022
EPS came in at -$0.12 .
Earnings released on 30 Dec 2021
EPS came in at -$0.13 .
Earnings released on 29 Sept 2021
EPS came in at -$0.20 .
Earnings released on 30 Jun 2021
EPS came in at -$0.14 .
Earnings released on 31 Mar 2021
EPS came in at -$0.09 .
Earnings released on 31 Dec 2020
EPS came in at -$0.06 .
Earnings released on 30 Sept 2020
EPS came in at -$0.05 .
RENB Stock Performance
Access detailed RENB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.